Vendor Intelligence Report: Modern Aminos

Published 13 Jun 2026. 26-page investigative report on who is behind Modern Aminos: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Across 5 Finnrick lab tests, Modern Aminos records 4 passes and 1 fail, an overall pass rate of 80%. Every test is Retatrutide, so the read is narrow: Modern Aminos has shipped lots that pass, but the captured table also contains an identity failure and a later vial that materially missed the vendor’s own batch claim. Stricter grading reduces the comfort of the headline rating, and current non-GLP items should not inherit it.

The company record is similarly narrow but consequential. The only legal entity surfaced is a Wyoming LLC at 30 N Gould St in Sheridan, a mass registered-agent address; the only named human operator is a self-reported Idaho-linked LinkedIn profile, with no matching Idaho or Delaware entity found. The supplied new.modernaminos.com contact lead did not resolve, while the live evidence centers on modernaminos.com and modernaminos.eu behind Cloudflare, ProtonMail, and a login-gated WooCommerce rebuild.

The reputational and recourse picture is not clean enough to treat community praise as independent. The report maps undisclosed referral-code activity across X, Reddit, and coupon sites, including r/ModernAminosGuide’s affiliate function and later pivot to Adera and Leo Research Group. It also documents a removed US Trustpilot profile, a negative-review EU profile, Bitcoin-heavy EU payments, aggressive anti-chargeback terms, and a GLP-1 discontinuation that complicates Retatrutide continuity.

Inside the full report:

  • Captured Finnrick Retatrutide results table, methodology-divergence chart, and Appendix A laboratory data.
  • Wyoming LLC registry trail, Idaho/Delaware negative searches, and 30 N Gould St address analysis.
  • Domain and platform review covering modernaminos.com, modernaminos.eu, Cloudflare, ProtonMail, and the login gate.
  • QA and COA verification review of Vanguard, Chromate, TrustPointe, and Freedom Diagnostics claims.
  • Affiliate scan across X, Reddit, coupon sites, and r/ModernAminosGuide’s pivot to Adera/Leo Research Group.
  • Payment and recourse analysis covering Trustpilot removal, EU Bitcoin use, and anti-chargeback terms.

Risk assessment

  • Retatrutide identity and batch-reliability risk — high: One of five Finnrick Retatrutide tests failed; captured results identify a no-Retatrutide identity failure and a March 2026 sample 21.7% below the vendor's batch claim.
  • Current-catalog testing-gap risk — medium: Finnrick data covers only Retatrutide, while Modern Aminos announced GLP-1 discontinuation; no Finnrick record covers current non-GLP products.
  • COA-verification and QA-claims risk — medium: QA pages list labs and batch testing, but accreditation/verification is uneven and COA-falsification allegations remain unresolved; buyers must verify COAs at the lab source.
  • Promotion and reputation-integrity risk — high: Affiliate scan found 17 promoters/placements, 14 with code/link and no clear disclosure; r/ModernAminosGuide used ref=REDDIT, and the US Trustpilot profile was removed for guideline violations.
  • Corporate opacity and accountability risk — medium: Wyoming LLC uses 30 N Gould St registered-agent address; beneficial owners are not public and operator evidence is mainly self-reported LinkedIn.
  • Payment and dispute-recourse risk — medium: Terms threaten fraud/law-enforcement escalation for unwarranted chargebacks; all-sales-final/7-day-return posture and EU Bitcoin payments reduce buyer recourse.
  • Regulatory-continuity risk for GLP-1 buyers — medium: GLP-1, GLP/GIP, GLP/GIP/Glucagon, cagrilintide and cagrisema were announced discontinued effective Dec. 31, 2025 under compliance pressure.
  • Brand-authenticity and trademark-confusion risk — medium: The MODERN AMINOS mark is owned by Modern Sports Nutrition LLC, while Modern Aminos uses US/EU domains and a dead new.modernaminos.com lead; official-channel verification is thin.